Full-Time

S/4HANA Purchase to Pay

P2P, Solution Consultant

Posted on 2/7/2026

Zeiss

Zeiss

1,001-5,000 employees

Manufactures high-precision optical instruments and devices

Compensation Overview

$105k - $125k/yr

+ Bonus + Commission

Company Does Not Provide H1B Sponsorship

Toronto, ON, Canada + 3 more

More locations: Wixom, MI, USA | Minneapolis, MN, USA | White Plains, NY, USA

In Person

Travel required; occasional trips to Germany; may increase for go-live/post-go-live across ZEISS locations in the Americas.

Category
Software Engineering (1)
Required Skills
SAP Products
Requirements
  • Proven experience as a solution consultant or architect in SAP transformation projects, particularly within the Purchase to Pay (P2P) domain.
  • In-depth knowledge of SAP S/4HANA technologies, including cloud integration, and their integration with third-party systems.
  • Comprehensive understanding of global template processes within the P2P and other related domains.
  • Relevant SAP certifications or equivalent professional qualifications.
  • Able to read and evaluate ABAP source code.
  • A bachelor’s degree in information technology, Computer Science, Business Administration, or a related field.
Responsibilities
  • Design and implement comprehensive SAP S/4HANA solutions tailored for the P2P process, ensuring seamless integration with satellite systems based on specified business and IT requirements.
  • Develop SAP P2P solutions to streamline procurement, purchasing and payment activities.
  • Develop and validate technical and functional specifications to align with global template processes and adhere to industry best practices whilst meeting business objectives.
  • Efficiently coordinate and direct development tasks towards global development factories, ensuring projects are completed on time and to high standards.
  • Set up master data, procurement processes, invoice processing, and payment workflows.
  • Integrate with external systems for vendor management, electronic invoicing and payment processing.
  • Facilitate clear and effective communication between development teams and stakeholders to ensure alignment and clarity on project objectives.
  • Provide expert guidance on SAP best practice architectures and technologies, significantly enhancing the capabilities of deployment teams.
  • Continuously evaluate and challenge any deviations from established processes, advocating strongly for standardization to maintain solution integrity.
  • Ensure strict adherence to established architecture principles and standards, maintaining consistent quality across all solutions.
  • Conduct thorough reviews of configuration and functional specification documents, managing the approval process to ensure compliance and accuracy.
  • Support comprehensive testing activities, including the coordination of bug-fixing efforts, to ensure the reliability and performance of deployed solutions.
  • Oversee the preparation and execution of test plans, ensuring they align with project timelines and uphold quality standards.
  • Provide essential support during cutover, migration, and hyper care phases, ensuring smooth transitions and stabilization of the end-to-end P2P process domain.
  • Address and resolve post-implementation issues, facilitating continuous improvement and optimization of deployed solutions.
  • Be the contact person in 2nd and 3rd level support for implemented SAP S/4 and R/3 systems.
  • Find and create solutions to current problems.
  • Carry out root cause analyses and develop solutions to resolve recurring errors
Desired Qualifications
  • Additional professional certifications in project management or related fields.
  • Proven experience in leading cross-functional teams in a multinational environment.
  • Demonstrated expertise in cloud solutions and their integration with SAP S/4HANA.
  • Proficiency in using project management tools and methodologies.

ZEISS is a global leader in optics and optoelectronics, serving medical professionals, industrial manufacturers, consumers, and the semiconductor industry. It designs and sells high-precision optical instruments, medical devices, semiconductor manufacturing equipment, and vision care products such as corrective lenses and eye-health services. Its products rely on advanced optics and imaging technologies to deliver accurate inspection, diagnosis, and manufacturing outcomes across healthcare, industrial quality control, consumer optics, and chip fabrication. What sets ZEISS apart is its breadth and depth: a long-standing scale in multiple markets, integrated solutions across optics, imaging, metrology, and precision engineering, and a commitment to sustainability in electricity use and carbon emissions. The company’s goal is to advance optics and optoelectronics by providing reliable, high-quality tools and services worldwide while operating in a sustainable way.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$1.1B

Headquarters

Oberkochen, Germany

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • NMPA approval accelerates ARTEVO 750/850 sales in China's ophthalmic market.
  • Collaborative Care app boosts data sharing, capturing digital health interoperability growth.
  • CALYPSO 2024 software upgrade generates recurring revenue from CMM customers.

What critics are saying

  • TSMC and Samsung capex cuts collapse Semiconductor Manufacturing Technology revenue.
  • Suoer and Kangyang erode ARTEVO pricing in saturated Chinese microscope market.
  • CLINIC 360 FDA delays stall AI diagnostic platform commercialization.

What makes Zeiss unique

  • ZEISS leads in AI-powered ophthalmic tools like VisioGen and ARTEVO microscopes.
  • Balanced revenue across semiconductor, medical, industrial, and consumer optics segments.
  • 175-year legacy drives precision innovations in four global business segments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Performance Bonus

Company News

PR Newswire
Apr 2nd, 2026
ZEISS unveils AI-powered patient platform and enhanced IOL tools at ASCRS

ZEISS has unveiled new digital, AI and surgical innovations for cataract and refractive workflows at the ASCRS conference. The medical technology company is expanding its US cataract portfolio with new irrigation/aspiration handpieces compatible with the DORC EVA NEXUS surgical system, alongside enhanced IOL calculation capabilities for the ZEISS IOLMaster 700. ZEISS also launched VisioGen commercially in the US, a human-verified AI patient engagement platform for ophthalmology practices. The platform integrates with clinic websites to capture patient demand around the clock, with AI-assisted responses reviewed by ZEISS-trained optometrists before delivery. The company showcased ZEISS Collaborative Care, a cloud-based application enabling secure data sharing between eye care professionals, and previewed ZEISS CLINIC 360, pending FDA clearance. ZEISS is celebrating 100 years of US operations this year.

PR Newswire
Mar 24th, 2026
ZEISS expands ophthalmic portfolio in Canada with new diagnostic lasers and workflow tools

ZEISS Medical Technology has expanded its ophthalmic workflow portfolio in Canada with new diagnostic, visualisation and therapeutic solutions. The company will showcase the innovations at upcoming Canadian ophthalmology conferences in Ottawa and Montréal. Key additions include ICGA for ZEISS CLARUS 700, offering simultaneous FA and ICG capture for clinical assessment, and ZEISS VISULAS green with selective laser trabeculoplasty for retinal photocoagulation. The company has introduced refraction devices ZEISS VISUREF 600 and ZEISS VISUCORE 500 to streamline diagnostic workflows. ZEISS also launched VISULAS yag, a new-generation therapeutic laser for anterior segment photodisruption within cataract workflows. The ZEISS FORUM subscription package, now available in Canada, offers integrated data management with unlimited device licences and lower upfront costs.

PR Newswire
Feb 23rd, 2026
ZEISS launches Collaborative Care app for eye care professionals with cloud and on-premises options

ZEISS Medical Technology has launched Collaborative Care, a browser-based application enabling eye care professionals to share data securely, refer patients and coordinate clinical care. Built on the ZEISS Health Data Platform, the solution addresses fragmented data sharing and inefficient referral processes in ophthalmic care. The application offers flexible deployment as either a standalone cloud solution or an integrated extension of ZEISS FORUM. Key features include secure exchange of images and reports, streamlined referral workflows with tracking capabilities, and tools for building professional networks between optometrists and ophthalmologists. ZEISS Collaborative Care was demonstrated at industry events in London and Orlando in February and March 2026. The company generated €2,228 million in revenue in fiscal year 2024/25 with 5,784 employees worldwide.

Handelsblatt
Feb 19th, 2026
Custom Surgical raises $4M to develop AI-powered ophthalmology platform

Custom Surgical, a German ophthalmology company, has raised €3.5 million to advance its platform. The funding will support development of AI-powered features including automated image optimisation and assisted triage processes that help determine case urgency and specialist assignment. The company is already developing its first AI-based triage and screening system. The technology aims to provide initial assessments that guide decisions on how urgently cases need attention and which medical professionals should handle them next.

Investors Hangout
Feb 18th, 2026
Mindpeak raises $15.3M Series A to scale AI cancer diagnostic tools

Mindpeak, an AI-driven pathology startup, raised $15.3 million in a Series A round led by ZEISS Ventures and InnoVentureFund in 2024. The funding will accelerate development and deployment of the company's AI diagnostic tools for cancer pathology. Founded in 2018, Mindpeak's algorithms have supported over 30,000 patient diagnoses across US and European healthcare markets. The technology uses automated histological analyses to help pathologists make faster, more precise clinical decisions. CEO Felix Faber stated the capital would expedite product rollouts and expand capabilities. The company has established strategic partnerships with major players including Roche. Mindpeak operates in the rapidly growing digital pathology market, driven by technological innovation and increasing demand for advanced diagnostic services in an ageing population.

INACTIVE